Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,217 public trials 94 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

NCT06795815

Conditions: Advanced Solid Tumors, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: AziendaUSL IRCCS Reggio Emilia Reggio Emilia, Italy

View Trial Details

Recruiting

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

NCT03058588

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Chair of Hematology and Bone marrow Transplant Unit Brescia, Italy

View Trial Details

Recruiting

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

NCT05536349

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia

NCT07556757

Conditions: B-ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Dr Jackie Thomson Inc Johannesburg, South Africa

Alberts Cellular Therapy Pretoria, South Africa

View Trial Details

Recruiting

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

NCT05646576

Conditions: Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

NCT06839456

Conditions: Acquired Aplastic Anemia, Anemia, Anemia, Refractory, +35 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions: AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

UCLA Health - Bowyer Oncology Center Los Angeles, California, United States

UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States

View all 45 locations

View Trial Details

Recruiting

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

NCT05544968

Conditions: CD30+ Anaplastic Large Cell Lymphoma, CD30+ Immunoblastic Large T-Cell Cutaneous Lymphoma, CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma, +19 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

Revumenib in Combination With 7+3 + Midostaurin in AML

NCT06313437

Conditions: AML, AML With Gene Mutations, AML, Adult, +8 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

NCT06890494

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Beijing GoBroad Hospital Beijing, China

View Trial Details